SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001585283-13-000025
Filing Date
2013-10-01
Accepted
2013-10-01 13:11:23
Documents
1
Period of Report
2013-09-27

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 10659
  Complete submission text file 0001585283-13-000025.txt   12720
Mailing Address 1221 AVENUE OF AMERICAS NEW YORK NY 10020
Business Address 1221 AVENUE OF THE AMERICAS NEW YORK NY 10020 212-761-4000
MORGAN STANLEY INVESTMENT MANAGEMENT INC (Reporting) CIK: 0001230193 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35144 | Film No.: 131126188

Mailing Address
Business Address ONE TOWER BRIDGE 100 FRONT STREET SUITE 1100 WEST CONSHOHOCKEN PA 19428
MORGAN STANLEY AIP GP LP (Reporting) CIK: 0001230207 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35144 | Film No.: 131126187

Mailing Address 1901 NORTH ROSELLE ROAD, SUITE 700 SCHAUMBURG IL 60195
Business Address 1901 NORTH ROSELLE ROAD, SUITE 700 SCHAUMBURG IL 60195 847-908-1604
Sagent Pharmaceuticals, Inc. (Issuer) CIK: 0001369786 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
SIC: 2834 Pharmaceutical Preparations